What's on the News?

• On Wednesday, the top-ranked stock by trading volume in the US market was Tesla Motors, Inc.(TSLA.US) , which rose by 3.50% to close at $321.67, with a trading volume of $30.728 billion. On the evening of July 16, Tesla's official website released the message "Model Y L, See You in the Golden Autumn," announcing that the new model will be launched and delivered in the fall of this year. It is understood that the Model Y L is a flagship model produced by Tesla's Gigafactory in Shanghai.
• 2nd-ranked NVIDIA Corporation(NVDA.US)  rose 0.39%, hitting another all-time high, with a trading volume of $269.69 billion. NVIDIA announced on Tuesday that it is submitting an application for the re-export of the H20 GPU. The US government has assured NVIDIA that it will grant the license, and NVIDIA hopes to start deliveries as soon as possible. Additionally, Huang Renxun also announced the launch of a brand-new and fully compatible NVIDIA RTX PRO GPU, which is described as the “ideal choice for creating digital twin AI for smart factories and logistics.”
• 3rd-ranked Apple Inc.(AAPL.US)  rose 0.50%, with a trading volume of $99.34 billion. Apple announced yesterday that it will invest $500 million in US rare earth miner MP Materials, sending an important signal. The goal is to expand the production of rare earth magnets in the US. Apple also plans to build new recycling and manufacturing plants.
• 4th-ranked Circle(CRCL.US) Internet rose 19.39%, with a trading volume of $96.43 billion. Digital currency - related stocks in the US market strengthened on Wednesday, following the procedural vote on cryptocurrency - related bills by the US House of Representatives.
• 5th-ranked Advanced Micro Devices, Inc.(AMD.US)  rose 2.87%, with a trading volume of $92.42 billion. Reports indicated that AMD will resume exports of its MI308 chips to China. AMD officials said: “We recently received notification from the Trump administration that the license application for the export of MI308 products to China will be advanced to the review process. We plan to resume shipments once the license is approved.”
• 6th-ranked Meta Platforms(META.US)    fell 1.05%, with a trading volume of $91.79 billion. After being fined €200 million by the EU, Meta Platforms still does not fully comply with the EU’s strict digital regulations, and the conflict between the two sides seems to be escalating.
• 7th-ranked Amazon.com, Inc.(AMZN.US)  fell 1.40%, with a trading volume of $87.81 billion. Bank of America removed Amazon from its “US 1 List” of preferred US stocks.
• 9th-ranked ASML Holding NV ADR(ASML.US)  fell 8.33%, with a trading volume of $80.14 billion. The company’s Q2 earnings per share were €5.90, €0.66 higher than the market - expected €5.24. Revenue grew 23.2% year - on - year to €7.69 billion, exceeding the market - expected €7.55 billion. However, ASML lowered its Q3 guidance, expecting Q3 revenue of €7.4 - 7.9 billion, below the market - expected €8.26 billion.
  The company also lowered its full - year 2025 guidance, expecting full - year revenue growth of 15% to €32.5 billion, below the market - expected €37.39 billion.
• 12th-ranked Alphabet Inc. Class A(GOOGL.US)  rose 0.53%, with a trading volume of $60.54 billion. UBS raised Alphabet’s target price from $186 to $192.
• 13th-ranked Coinbase(COIN.US)  Global rose 2.62%, with a trading volume of $56.43 billion. The cryptocurrency sector in the US market generally rose on Wednesday, following comments from the chair of the House Financial Services Committee, who said there are enough votes to pass a stablecoin bill. The House has the votes to advance three cryptocurrency measures.
• 14th-ranked Robinhood(HOOD.US)  rose 3.73%, with a trading volume of $55.97 billion.
• 15th-ranked MicroStrategy Incorporated Class A(MSTR.US)  rose 3.07%, with a trading volume of $47.3 billion.
• 20th-ranked Johnson & Johnson(JNJ.US)  rose 6.19%, with a trading volume of $35.94 billion. The company’s Q2 results exceeded Wall Street expectations and it raised its full - year guidance, showing confidence in the face of Trump’s tax and drug - pricing threats in the pharmaceutical industry. The company reported Q2 sales of $23.7 billion, above analysts’ average estimate of $22.8 billion. Q2 non - GAAP earnings per share were $2.77, $0.09 above expectations. J&J raised its full - year 2025 revenue forecast midpoint by $2 billion to $93.4 billion and its full - year adjusted EPS forecast midpoint to $10.80 - $10.90.